BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17706778)

  • 1. Vaccination against the feline immunodeficiency virus: the road not taken.
    Lecollinet S; Richardson J
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
    Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.
    Osterhaus AD; Weijer K; Siebelink KH; Rimmelzwaan GF; Bosch ML
    J Am Vet Med Assoc; 1991 Nov; 199(10):1443-6. PubMed ID: 1666100
    [No Abstract]   [Full Text] [Related]  

  • 7. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
    Yamamoto JK; Pu R; Sato E; Hohdatsu T
    AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
    Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
    J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against feline retrovirus infections].
    Horzinek MC
    Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
    Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
    Kahler SC;
    J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine protection against feline immunodeficiency virus: setting the challenge.
    Zwijnenberg R; Yamamoto JK
    Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
    [No Abstract]   [Full Text] [Related]  

  • 14. [Feline immunodeficiency virus].
    Martinon O; Lévy D
    Vet Res; 1993; 24(2):151-8. PubMed ID: 8393723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New challenges for the diagnosis of feline immunodeficiency virus infection.
    Crawford PC; Levy JK
    Vet Clin North Am Small Anim Pract; 2007 Mar; 37(2):335-50, vii. PubMed ID: 17336678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feline immunodeficiency virus as a model for AIDS vaccination.
    Jarrett O; Yamamoto JK; Neil JC
    AIDS; 1990; 4 Suppl 1():S163-5. PubMed ID: 1967108
    [No Abstract]   [Full Text] [Related]  

  • 20. FIV and HIV vaccines--problems and prospects.
    Harbour DA
    Br Vet J; 1994; 150(1):7-8. PubMed ID: 8025838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.